Search research articles
Contact Us
Filters
Showing results (1-10 of 81) with videos related to
Page
of 9
Sort By:
Lancet (London, England)
|
May 1, 2007
Piperazine designer drugs of abuse
Roland F Staack
Analytical and Bioanalytical Chemistry
|
June 23, 2007
New analytical strategies in studying drug metabolism
Roland F Staack, Gérard Hopfgartner
Bioanalysis
|
July 8, 2020
Toward comparability of anti-drug antibody assays: is the amount of anti-drug antibody-reagent complexes at cut-point (CP-ARC) the missing piece?
Gregor Jordan, Roland F Staack
The AAPS Journal
|
August 14, 2021
An Alternative Data Transformation Approach for ADA Cut Point Determination: Why Not Use a Weibull Transformation?
Gregor Jordan, Roland F Staack
Bioanalysis
|
February 10, 2023
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?
Gregor Jordan, Roland F Staack
The AAPS Journal
|
January 23, 2026
Advancing Quantitative ADA Detection Through Model Informed Assay Development (MIAD)
Gregor Jordan, Roland F Staack
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 15, 2004
Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry
Roland F Staack, Hans H Maurer
Journal of Analytical Toxicology
|
December 13, 2003
Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone
Roland F Staack, Hans H Maurer
Journal of Mass Spectrometry : JMS
|
March 25, 2004
New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry
Roland F Staack, Hans H Maurer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 4, 2003
Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry
Roland F Staack, Hans H Maurer
Page
of 9
Search research articles
Search
Showing results (1-10 of 81) with videos related to
Sort By:
Page
of 9
Lancet (London, England)
|
May 1, 2007
Piperazine designer drugs of abuse
Roland F Staack
Analytical and Bioanalytical Chemistry
|
June 23, 2007
New analytical strategies in studying drug metabolism
Roland F Staack, Gérard Hopfgartner
Bioanalysis
|
July 8, 2020
Toward comparability of anti-drug antibody assays: is the amount of anti-drug antibody-reagent complexes at cut-point (CP-ARC) the missing piece?
Gregor Jordan, Roland F Staack
The AAPS Journal
|
August 14, 2021
An Alternative Data Transformation Approach for ADA Cut Point Determination: Why Not Use a Weibull Transformation?
Gregor Jordan, Roland F Staack
Bioanalysis
|
February 10, 2023
Direct bioanalysis or indirect calculation of target engagement and free drug exposure: do we apply double standards?
Gregor Jordan, Roland F Staack
The AAPS Journal
|
January 23, 2026
Advancing Quantitative ADA Detection Through Model Informed Assay Development (MIAD)
Gregor Jordan, Roland F Staack
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
April 15, 2004
Studies on the metabolism and the toxicological analysis of the nootropic drug fipexide in rat urine using gas chromatography-mass spectrometry
Roland F Staack, Hans H Maurer
Journal of Analytical Toxicology
|
December 13, 2003
Piperazine-derived designer drug 1-(3-chlorophenyl)piperazine (mCPP): GC-MS studies on its metabolism and its toxicological detection in rat urine including analytical differentiation from its precursor drugs trazodone and nefazodone
Roland F Staack, Hans H Maurer
Journal of Mass Spectrometry : JMS
|
March 25, 2004
New designer drug 1-(3,4-methylenedioxybenzyl) piperazine (MDBP): studies on its metabolism and toxicological detection in rat urine using gas chromatography/mass spectrometry
Roland F Staack, Hans H Maurer
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
December 4, 2003
Toxicological detection of the new designer drug 1-(4-methoxyphenyl)piperazine and its metabolites in urine and differentiation from an intake of structurally related medicaments using gas chromatography-mass spectrometry
Roland F Staack, Hans H Maurer
Page
of 9